Author
Brigham and Women's HospitalORCID 0000-0001-7816-3924Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Filipe L.F. Carvalho, Ji‐Hyun Lee, Nikolaos Kalavros…·Eliezer M. Van Allen
This study identifies tumor-myeloid crosstalk as a driver of cisplatin resistance in bladder cancer and proposes PARP14 inhibition as a therapeutic strategy.
Carlos Wagner S Wanderley, Daniel E. Michaud, Kenichi Shimada…·Jennifer L. Guerriero
The paper identifies distinct immune and stromal features in HR+ HER2-low and HER2-0 breast cancers using molecular and multiplexed imaging.
Konrad Stawiski, Júlia Perera‐Bel, Alejo Rodríguez‐Vida…·Joaquim Bellmunt B
The paper examines how platinum-based chemotherapy affects tumor immune microenvironments in urothelial cancer, finding that memory B cell infiltration correlates with improved survival in cisplatin-treated patients.
Kenichi Shimada, Daniel E. Michaud, Yvonne Xiaoyong Cui…·Jennifer L. Guerriero
This study identifies an estrogen receptor signaling program in HR+ breast cancer that suppresses immune responses by reducing T cell infiltration and HLA expression, suggesting therapeutic targets to enhance immunogenicity.